Work

A phase I clinical trial with weekly irinotecan (IRI) and capecitabine (CAP) in patients with advanced gastrointestinal and other solid malignancies

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.2113

Authors: D. T. Friedman, S. Goel, K. Desai, D. Verdier-Pinard, A. Kaubisch, A. Bulgaru, F. Camacho, G. Goldberg, S. Mani

Institution: Montefiore Einstein Comprehensive Cancer Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2249436328

Cites:

Cited by: 1

Related to: 10